Lixte Biotechnology Holdings Overview
Lixte Biotechnology Holdings Discounted Cash Flow
DCF Analysis for LIXT.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.09
Current Fair Value
$0.09
↓ 98.6% Downside
Overvalued by 98.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison